Globe Biotech claims to be 1st Bangladeshi company to develop Covid-19 vaccine

The company is currently undertaking preliminary tests with animal modelling

FILE PHOTO: Small bottles labeled with a “Vaccine COVID-19” sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

Globe Biotech Limited has claimed to be the first company in Bangladesh to have a Covid-19 vaccine under development.

The company is currently undertaking preliminary tests with animal modelling, using rabbits and mice as test subjects.

Asif Mahmood, a scientist working for Globe Biotech, made the announcement at a press briefing in the Globe Biotech headquarters at around 12:10pm on Thursday.

The preliminary tests are set to conclude within four to six weeks, after which the company will seek ethical approvals from the Bangladesh Medical Research Council (BMRC), he said.

When (and if) they acquire those approvals, the company will be ready to move on to human trials through third party under the supervision of the Directorate General of Drug Administration (DGDA) in order to assess the effectiveness of the drug.


Harunur Rashid, chairman of Globe Biotech Limited, said: “Importing coronavirus vaccines from abroad is surely going to be very expensive, whenever that happens. We cannot yet say what the exact price of our solution will be. But our target is to produce something affordable.”